The global spirometer market size was estimated to be USD 1.19 billion in 2023 and is expected to reach at USD 3.55 billion by 2034 with a CAGR of 10.46% during the forecast period 2024-2034. Rising prevalence of chronic respiratory diseases such as COPD, increasing preference for home healthcare, growing technological advancements in the field of spirometers, surge in initiatives to provide pediatric care & the use of contemporary spirometry equipment that standardizes outcomes of tests and delivers prompt replies, rising preference for home healthcare, increasing focus on development of tele-spirometers, growing patient awareness regarding cutting-edge diagnostic techniques, surge in research & development activities to develop more efficient products, and increasing launch of technologically advanced spirometry solutions are some of the key factors boosting the market growth.
Increasing launch of technologically advanced spirometry solutions is predicted to boost the market growth during the forecast period. Spirometry equipment plays a crucial role in diagnosing various respiratory diseases, especially in occupational settings. To streamline the intricate process of conducting pulmonary function tests for both patients and healthcare providers, manufacturers are working on enhancing the design and capabilities of spirometers. The primary goal is to create spirometers that offer better performance and increased patient comfort while minimizing potential complications. These technological advancements aim to simplify testing procedures, making them more accessible and user-friendly for patients. For instance, in March 2023, Vitalograph, a company specializing in respiratory diagnostic equipment, has introduced the VitaloPFT Pulmonary Function Testing Series, designed for utilization in secondary healthcare settings.
By product, devices was the highest revenue-grossing segment in the global spirometer market in 2023 owing to the extensive use of table top devices in the treatment of lung disorders, including as COPD, asthma, & other illnesses, rising adoption of portable spirometers as these devices can store hundreds of diagnostic test results & can print the results on standard printers, and increasing partnerships & collaborations within market players. For instance, in August 2022, AstraZeneca has collaborated with Alveofit, a respiratory healthcare platform, to provide Internet of Things (IoT)-enabled portable spirometers to hospitals nationwide. These handheld spirometers are connected to the IoT, enabling remote patient monitoring and tele-spirometry with comprehensive care management solutions. Additionally, software is predicted to grow at fastest CAGR during the forecast period owing to the rapid access to patient information, increasing adoption of technologically advanced platforms, and growing launch of advanced solutions by market players.
By technology, flow measurement was the highest revenue-grossing segment in the global spirometer market in 2023 owing to its several uses for pulmonary function assessment and increasing preference in office & hospital settings. Additionally, peak flow measurement is predicted to grow at fastest CAGR during the forecast period as they serve as alerts prior to an asthma attack by showing the constriction of the lung airways, increase in the use of mobile applications that allow patients to record their peak flow and FEV1 measures at home & communicate the information to their doctors electronically, and growing launch of novel software platforms. For instance, in April 2022, PulManage Inc. has introduced the PulManage software platform, specially designed to tackle challenges related to the diagnosis and treatment of chronic lung diseases. It is now accessible for remote spirometry and respiratory monitoring.
By application, COPD was the highest revenue-grossing segment in the global spirometer market in 2023 owing to surge in number of people suffering from COPD, the quick detection of COPD using spirometry, and increasing collaborations within market players. For instance, in September 2022, RxCap, Inc., known for its expertise in cloud-based remote monitoring solutions, has partnered with ZEPHYRx LLC, a company offering remote respiratory monitoring solutions, to combine the ZEPHYRx cloud spirometry platform with RxCap's remote monitoring platform. Additionally, asthma is predicted to grow at fastest CAGR during the forecast period owing to the rising prevalence of asthma, increasing technological advancements, and growing adoption of mobile applications capable of diagnosing asthma.
By end-user, hospitals & clinics was the highest revenue-grossing segment in the global spirometer market in 2023 owing to increasing adoption of spirometers in hospitals & clinics for diagnosis & monitoring of chronic respiratory disorders, growing geriatric population, rising reimbursements for clinical tests performed in hospitals, surge in adoption of smart devices, and increasing launch of advanced devices. Additionally, home healthcare is predicted to grow at fastest CAGR during the forecast period owing to the growing technological advancements, increasing demand for battery operated spirometers for daily use, surge in adoption of telemedicine, and rising research & development activities. For instance, in March 2023, NuvoAir delivered a research study titled "Evaluation of Home Spirometry Quality and Compliance in a Remote Assessment Led by Respiratory Physiologists" during the Association for Respiratory Technology and Physiology (ARTP) Annual Conference held in Brighton. The presented poster summarized findings from a retrospective examination of NuvoAir's 12-week Asthma Assessment Service in the United Kingdom, highlighting its influence on precise diagnosis, effective management, and treatment of respiratory ailments.
North America region is anticipated for the highest revenue share during the forecast period owing to the growing prevalence of respiratory diseases, rising adoption of cutting-edge technologies, and increasing research & development activities. For instance, in January 2023, Koneksa, a healthcare technology firm dedicated to creating scientifically supported digital biomarkers, has unveiled a clinical research project that aims to compare the treatment outcomes for patients with moderate asthma undergoing long-acting beta-agonist (LABA) treatment. This study will assess the effectiveness of at-home mobile spirometry utilizing digital biomarkers in contrast to traditional in-clinic spirometry. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rising demand for early detection & management of COPD and asthma, increasing technological advancements, and surge in collaborations within market players. For instance, in September 2023, Beyond Air, Inc. has recently made an agreement with Getz Healthcare to market the LungFit PH device in specific countries within the Asia-Pacific area, subject to regulatory approvals.
Increasing launch of technologically advanced spirometry solutions is predicted to boost the market growth during the forecast period. Spirometry equipment plays a crucial role in diagnosing various respiratory diseases, especially in occupational settings. To streamline the intricate process of conducting pulmonary function tests for both patients and healthcare providers, manufacturers are working on enhancing the design and capabilities of spirometers. The primary goal is to create spirometers that offer better performance and increased patient comfort while minimizing potential complications. These technological advancements aim to simplify testing procedures, making them more accessible and user-friendly for patients. For instance, in March 2023, Vitalograph, a company specializing in respiratory diagnostic equipment, has introduced the VitaloPFT Pulmonary Function Testing Series, designed for utilization in secondary healthcare settings.
By product, devices was the highest revenue-grossing segment in the global spirometer market in 2023 owing to the extensive use of table top devices in the treatment of lung disorders, including as COPD, asthma, & other illnesses, rising adoption of portable spirometers as these devices can store hundreds of diagnostic test results & can print the results on standard printers, and increasing partnerships & collaborations within market players. For instance, in August 2022, AstraZeneca has collaborated with Alveofit, a respiratory healthcare platform, to provide Internet of Things (IoT)-enabled portable spirometers to hospitals nationwide. These handheld spirometers are connected to the IoT, enabling remote patient monitoring and tele-spirometry with comprehensive care management solutions. Additionally, software is predicted to grow at fastest CAGR during the forecast period owing to the rapid access to patient information, increasing adoption of technologically advanced platforms, and growing launch of advanced solutions by market players.
By technology, flow measurement was the highest revenue-grossing segment in the global spirometer market in 2023 owing to its several uses for pulmonary function assessment and increasing preference in office & hospital settings. Additionally, peak flow measurement is predicted to grow at fastest CAGR during the forecast period as they serve as alerts prior to an asthma attack by showing the constriction of the lung airways, increase in the use of mobile applications that allow patients to record their peak flow and FEV1 measures at home & communicate the information to their doctors electronically, and growing launch of novel software platforms. For instance, in April 2022, PulManage Inc. has introduced the PulManage software platform, specially designed to tackle challenges related to the diagnosis and treatment of chronic lung diseases. It is now accessible for remote spirometry and respiratory monitoring.
By application, COPD was the highest revenue-grossing segment in the global spirometer market in 2023 owing to surge in number of people suffering from COPD, the quick detection of COPD using spirometry, and increasing collaborations within market players. For instance, in September 2022, RxCap, Inc., known for its expertise in cloud-based remote monitoring solutions, has partnered with ZEPHYRx LLC, a company offering remote respiratory monitoring solutions, to combine the ZEPHYRx cloud spirometry platform with RxCap's remote monitoring platform. Additionally, asthma is predicted to grow at fastest CAGR during the forecast period owing to the rising prevalence of asthma, increasing technological advancements, and growing adoption of mobile applications capable of diagnosing asthma.
By end-user, hospitals & clinics was the highest revenue-grossing segment in the global spirometer market in 2023 owing to increasing adoption of spirometers in hospitals & clinics for diagnosis & monitoring of chronic respiratory disorders, growing geriatric population, rising reimbursements for clinical tests performed in hospitals, surge in adoption of smart devices, and increasing launch of advanced devices. Additionally, home healthcare is predicted to grow at fastest CAGR during the forecast period owing to the growing technological advancements, increasing demand for battery operated spirometers for daily use, surge in adoption of telemedicine, and rising research & development activities. For instance, in March 2023, NuvoAir delivered a research study titled "Evaluation of Home Spirometry Quality and Compliance in a Remote Assessment Led by Respiratory Physiologists" during the Association for Respiratory Technology and Physiology (ARTP) Annual Conference held in Brighton. The presented poster summarized findings from a retrospective examination of NuvoAir's 12-week Asthma Assessment Service in the United Kingdom, highlighting its influence on precise diagnosis, effective management, and treatment of respiratory ailments.
North America region is anticipated for the highest revenue share during the forecast period owing to the growing prevalence of respiratory diseases, rising adoption of cutting-edge technologies, and increasing research & development activities. For instance, in January 2023, Koneksa, a healthcare technology firm dedicated to creating scientifically supported digital biomarkers, has unveiled a clinical research project that aims to compare the treatment outcomes for patients with moderate asthma undergoing long-acting beta-agonist (LABA) treatment. This study will assess the effectiveness of at-home mobile spirometry utilizing digital biomarkers in contrast to traditional in-clinic spirometry. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rising demand for early detection & management of COPD and asthma, increasing technological advancements, and surge in collaborations within market players. For instance, in September 2023, Beyond Air, Inc. has recently made an agreement with Getz Healthcare to market the LungFit PH device in specific countries within the Asia-Pacific area, subject to regulatory approvals.
Segmentation: Spirometer Market Report 2023 - 2034
Spirometer Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Consumables & Accessories
- Software
- Devices
- Table Top
- Hand Held
- Desktop
Spirometer Market Analysis & Forecast by Technology 2023 - 2034 (Revenue USD Bn)
- Flow Measurement
- Peak Flow Measurement
- Volume Measurement
Spirometer Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- COPD
- Cystic Fibrosis
- Asthma
- Pulmonary Fibrosis
- Others
Spirometer Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Home Healthcare
- Hospitals & Clinics
Spirometer Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Spirometer Market: Product Estimates & Trend Analysis
8. Spirometer Market: Technology Estimates & Trend Analysis
9. Spirometer Market: Application Estimates & Trend Analysis
10. Spirometer Market: End-user Estimates & Trend Analysis
11. Regional Market Analysis
12. North America Spirometer Market
13. Europe Global Spirometer Market
14. Asia Pacific Global Spirometer Market
15. Latin America Global Spirometer Market
16. MEA Global Spirometer Market
17. Competitor Analysis
18. Company Profiles
Companies Mentioned
- Vitalograph
- Vyaire Medical Inc.
- AstraZeneca
- PulManage Inc.
- RxCap Inc.
- SDI Diagnostics
- Schiller
- Welch Allyn
- Smiths Medical
- Koninklijke Philips N.V.
- Sibelmed
- Fukuda Sangyo Co. Ltd.
- Geratherm Respiratory AG
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | January 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 1.19 Billion |
| Forecasted Market Value ( USD | $ 3.55 Billion |
| Compound Annual Growth Rate | 10.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 13 |
